Michael Petusky

Barrington Research: With SEC Litigation Settled, Opko Health Should Outperform

Anika Therapeutics Shares Stunted By Increased Investment, Barrington Says In Downgrade

Analyst: Don't Expect Anika's Latest FDA Cleared Treatment To Impact 2018

Anika Therapeutics Shares Stunted By Increased Investment, Barrington Says In Downgrade

Analyst: Don't Expect Anika's Latest FDA Cleared Treatment To Impact 2018

Barrington Getting Constructive On Primo Water, Upgrades To Outperform

Opko Health Has Crashed 55% In Three Months; Time To Buy?

Barrington Getting Constructive On Primo Water, Upgrades To Outperform

Opko Health Has Crashed 55% In Three Months; Time To Buy?

Barrington Research Assumes Coverage On Opko Health On Positive Outlook

Barrington Research Reassumes Coverage DENTSPLY On Limited Upside

Michael Petusky Recent News

Barrington Research Initiates Coverage On Healthways, Cites Strong Macro Environment

UPDATE: Barrington Research Initiates Coverage On Providence Service

UPDATE: Barrington Research Initiates Coverage On Primo Water

UPDATE: Barrington Research Initiates Coverage On PharMerica

UPDATE: Barrington Research Initiates Coverage On BioScrip On Positive Outlook

UPDATE: Barrington Research Assumes Coverage On Haemonetics On Positive Revenue Outlook

UPDATE: Noble Financial Downgrades Hanger